Retatrutide Clinical Trial

Infographic of the retatrutide study

🌟 “Retatrutide: The New Hope in Diabetes Management!” 🌟

When it comes to managing type 2 diabetes, it’s not just about blood sugar. Keeping a healthy weight is just as crucial! Enter Retatrutide – a promising new drug that’s showing real potential.

🚀 What’s Special About Retatrutide? This isn’t just your regular diabetes drug. Retatrutide combines the benefits of THREE different diabetes treatments in one! A recent study decided to test how good it really is.

🔍 Study Details:

  • Setting: 42 research centers in the USA.
  • Participants: Adults with type 2 diabetes, aged 18-75, who are either managing their diabetes with diet and exercise or a stable dose of the drug metformin.
  • Duration: 36 weeks.

🔥 Hot Findings:

  1. Blood Sugar Levels: After 24 weeks, almost all dosages of retatrutide lowered blood sugar levels more than a placebo. The higher the dose, the better the results!
  2. Weight Loss Win: By week 36, those on retatrutide lost weight! And we’re not talking just a pound or two. Depending on the dose, some people shed nearly 17% of their body weight. 🏋️
  3. Side Effects?: Like most drugs, there were some. Common side effects were mild stomach issues. But the good news? No severe low blood sugar episodes and no reported deaths during the study.

đź“Ł What This Means: Retatrutide is shaping up to be a game-changer in type 2 diabetes treatment. Not only does it help manage blood sugar levels, but it also helps people shed the extra pounds! Stay tuned as it heads to phase 3 trials.

📜 Registered under: ClinicalTrials.gov, NCT04867785. 🤝 Funded by: Eli Lilly and Company.

>